Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis

Gastroenterology

Volumn 115, Issue 1, 1998, Pages 19-27

  Cawley, H M ^a   Meltzer, S J ^a   De Benedetti, V M G ^a   Hollstein, M C ^a   Muehlbauer, K R ^a   Liang, L ^a   Bennett, W P ^a   Souza, R F ^a   Greenwald, B D ^a   Cottrell, J ^a   Salabes, A ^a   Bartsch, H ^a   Trivers, G E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

P53 ANTIBODY; PROTEIN ANTIBODY; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; ENZYME IMMUNOASSAY; ESOPHAGUS CARCINOMA; GEL ELECTROPHORESIS; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 18144433704     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70360-9     Document Type: Article

References (46)

1. AM Davidoff JD Iglehart JR Marks Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancer Proc Natl Acad Sci USA 89 1992 3439 3442
2. SF Winter JD Minna BE Johnson T Takahashi AF Gazdar DP Carbone Development of antibodies against p53 in lung cancer patients appears to be dependent upon the type of p53 mutation Cancer Res 53 1992 4168 4174
3. DG Guinee Jr WD Trivis GE Trivers VMG De Benedetti H Cawley J Welsh W Bennett J Jett TV Colgy SL Tazelaar Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and c-erbB-2 expression Carcinogenesis 16 1995 993 1002
4. CP Wild M Ridanpää S Anttila R Lubin T Soussi K Husgafvel-Pursiainen H. Vainio p53 Antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumor tissue Int J Cancer (Pred Oncol) 64 1995 176 181
5. M von Brevern M Hollstein H Cawley V De Benedetti WP Bennett L Liang A-G He SM Zhu T Tursz N Janin GE Trivers Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors Cancer Res 56 1996 4917 4921
6. LV Crawford DC Pim RD Bulbrook Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer Int J Cancer 30 1982 403 408
7. B Schlichtholz Y Legros D Gillet C Gaillard M Marty D Lane F Calvo T. Soussi The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hotspot Cancer Res 52 1992 6380 6384
8. JA Green B Mudenda J Jenkins SJ Leinster M Tarunina B Green L. Robertson Serum p53 auto-antibodies: incidence in familial breast cancer Eur J Cancer 30A 1994 580 584
9. R Lubin G Zalcman L Bouchet J Tredaniel Y Legros D Cazals A Hirsch T. Soussi Serum p53 antibodies as early markers of lung cancer Nat Med 1 1995 701 702
10. M Volkmann M Muller WJ Hoffmann M Meyer J Hagelstein U Rath B Kommerell H Zentgraf PR Galle The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and dependent of the alpha-fetoprotein status Hepatology 18 1993 559 565
11. GE Trivers HL Cawley VMG DeBenedetti M Hollstein MJ Marion WP Bennett ML Hoover C Prives C Tamburro CC Harris Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride J Natl Cancer Inst 87 1995 1400 1407
12. K Angelopoulou EP Diamandis DJA Sutherland JA Kellen PS Bunting Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers Int J Cancer 58 1994 480 487
13. GE Trivers VMG DeBenedetti HL Cawley G Caron AM Harrington WB Bennett JR Jett TV Colby PP Tazelaar RD Miller CC Harris Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease (COPD) can predate a diagnosis of cancer Clin Cancer Res 2 1996 1767 1775
14. JA Roth AS Lichter JB Pitnam AA Forastiere Cancer of the esophagus 4th ed VT DeVita Jr S Hellman SA Rosenberg Cancer: principles & practice of oncology. 1993 Lippincott Philadelphia 776 817
15. SJ Spechler Barrett's esophagus: current opinion Gastroenterology 8 1992 573 578
16. WJ Blot SS Devesa RW Kneller JF Fraumeni Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
17. WJ Blot SS Devesa RW Kneller JF Fraumeni Jr. Continuing climb in rates of esophageal adenocarcinoma: an update JAMA 270 1993 1320
18. E Achkar WC Carey The cost of surveillance for adenocarcinoma complicating Barrett's esophagus Am J Gastroentrol 83 1988 291 294
19. R Montesano M Hollstein P. Hainaut Molecular etiopathogenesis of esophageal cancers Ann 1st Super Sanita 32 1996 73 84
20. MC Hollstein RA Metcalf JA Welsh R Montesano CC Harris Frequent mutation of the p53 gene in human esophageal cancer Proc Natl Acad Sci 87 1990 9958 9961
21. W Bennett M Hollstein RA Metcalf J Welsh A He S-M Zhu I Kusters JH Resau BJ Trump DP Lane CC Harris p53 mutations and protein accumulation during multistage human esophageal carcinoma Cancer Res 53 1992 6092 6097
22. MP Audrezet M Robaszkiewicz B Mercier JB Nousbaum JP Bail E Hardy A Volant P Lozach JF Charles H Gouerou C. Ferec TP53 gene mutation profile in esophageal squamous cell carcinomas Cancer Res 53 1993 5745 5749
23. YY Liang A Esteve G Martel-Planche S Takahashi S-H Lu R Montesano M. Hollstein p53 mutations in esophageal tumors from high-incidence areas of China Int J Cancer 61 1995 611 614
24. Y Huang SJ Meltzer J Yin Y Tong EH Chang S Srivastava T McDaniel RF Boynton Z-Q Zou Altered mRNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas Cancer Res 53 1993 1889 1894
25. RL Blount SJ Meltzer J Yin Y Huang MJ Krasna BJ Reid Clonal ordering of 17p and 5q allelic losses in Barrett's dysplasia and adenocarcinoma Proc Natl Acad Sci USA 90 1993 3221 3225
26. JH Moore EJ Lesser DH Erdody RB Hatale MB Orringer DG Beer Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma Int J Cancer 56 1994 487 493
27. R Hamelin JF Flejoou F Muzeau F Potet P Laurent-Puig F Fekete G. Thomas TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus Gastroenterology 107 1994 1012 1018
28. AG Casson B Manolopoulos M Trodter N Kervliet F Omalley R. Inculet Clinical implications of p53 gene mutations in the progression of Barrett's epithelium to invasive esophageal cancer Am J Surg 167 1994 52 57
29. AG Casson N Kerkvliet F. Omalley Prognostic value of p53 in oesophageal adenocarcinoma J Surg Oncol 60 1995 5 11
30. RH Hardwick NA Shepard M Moorghen PV Newcomb D. Alderson Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence Gut 354 1994 704 708
31. PL Blount PC Galipeau CA Sanchez K Neshat DS Levine J Yin H Suzuki JM Abraham SJ Meltzer BJ Reid 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy Cancer Res 54 1994 2292 2295
32. BD Greenwald Y Huang R Baum SJ Meltzer Barrett's carcinoma in a 25-year-old man with point mutation of the p53 tumor suppressor gene Int J Oncol 1 1992 271 275
33. M Younes RM Lebovitz LV Lechago J. Lechago p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study Gastroenterology 105 1993 1637 1642
34. PJ Symmans JM Linehan MJ Brito MI Filipe p53 expression in Barrett's oesophagus, dysplasia, and adenocarcinoma using antibody DO-7 J Pathol 173 1994 221 226
35. S Ramel BJ Reid CA Sanchez PL Blount DS Levine K Neshat RC Haggitt PJ Dean K Thor PS Rabinovitch Evaluation of p53 in Barrett's esophagus by two-parameter flow cytometry Gastroenterology 102 1992 1220 1228
36. KK Krishnatath M van Blankenstein HW Tilanus Prognostic value of p53 in Barrett's oesophagus Eur J Gastroenterol Hepatol 7 1995 81 84
37. AM Mandard J Marnay S Lebeau JC Mandard Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus with special reference to uninvolved mucosa J Pathol 181 1997 153 157
38. N Munoz M Crespi A Grassi B Aramesh G Amiri A. Mojtabai Precursors of esophageal cancer in high-risk populations in Iran and China Lancet 1 1982 876 879
39. M Crespi N Munoz A Grassi S Qiong WK Jing LJ Jien Precursor lesions of oesophageal cancer in a low-risk population in China: comparison with high-risk populations Int J Cancer 34 1984 599 602
40. JJ Langone HB Gjika H. Van Vunakis Nicotine and its metabolites: radioimmunoassays for nicotine and cotinine Biochemistry 12 1973 5025 5030
41. VMG De Benedetti LB Travis JA Welsh FE van Leeuwen M Stovall EA Clarke JD Boice Jr WP Bennett p53 mutations in lung cancer following radiation therapy for Hodgkin's disease Cancer Epidemiol Biomarkers Prev 5 1996 93 98
42. R Hamelin N Jego P Laurent–Puig M Vidaud G. Thomas Efficient screening of p 53 mutations by denaturing gradient gel electrophoresis in colorectal tumors Oncogene 8 1993 2213 2220
43. B Renault M van den Broek R Fodde J Wijnen NS Pellegata D Amadori PM Khan GN Ranzani Base transitions are the most frequent genetic changes at p53 in gastric cancer Cancer Res 53 1993 2614 2617
44. JL Kelsey AS Whittlemore AS Evans WD Thompson Measurement error 2nd ed JL Kelsey AS Whittlemore AS Evans WD Thompson Methods in observational epidemiology. 1996 Oxford University New York 341 363
45. J-P Peyrat J Bonneterre R Lubin L Van lemmens L Vaniemmens J Fournier T. Soussi Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer Lancet 345 1995 621 622
46. S Uchino T Saito M Inomata N Osawa K Chikula K Etoh M. Kobayashi Prognostic significance of p53 mutation in esophageal cancer Jpn J Clin Oncol 26 1996 287 292